Skip to main content
. 2019 Summer;14(3):197–205. doi: 10.30699/ijp.2019.90356.1861

Table1.

The prevalence of HPV genotypes as a single infection in Iranian female and male population

Sex
Male Female
%, 95% CI No %, 95% CI No HPV Genotypes
66.5 (64.0-68.9) 828 26.1 (24.8-27.6) 1004 6 LR HPV
10.5 (8.8-12.1) 131 5.2 (4.5-6.0) 201 11
1.4 (0.8-2.2) 18 0.7 (0.4-0.9) 26 44
0.2 (0.0-0.6) 3 1.1 (0.8-1.4) 42 54
0.2 (0.0-0.4) 2 0.7 (0.4-0.9) 26 62
0 (0.0-0.0) 0 0.5 (0.3-0.8) 20 89
0 (0.0-0.0) 0 0.2 (0.1-0.4) 9 43
0 (0.0-0.0) 0 0.2 (0.1-0.4) 9 40
0 (0.0-0.0) 0 0.4 (0.3-0.7) 17 61
0 (0.0-0.0) 0 0.2 (0.1-0.4) 9 67
0 (0.0-0.0) 0 0.3 (0.1-0.4) 10 81
0 (0.0-0.0) 0 0.2 (0.1-0.4) 8 83
0.2 (0.0-0.6) 3 0.3 (0.1-0.4) 10 42
0.2 (0.0-0.6) 3 2.8 (2.3-3.4) 108 53 pHR HPV
0.5 (0.2-0.9) 6 1.7 (1.3-2.1) 65 66
0 (0.0-0.0) 0 0.3 (0.1-0.4) 10 26
0.1 (0.0-0.2) 1 0.3 (0.2-0.5) 12 73
0.1 (0.0-0.2) 1 0.3 (0.1-0.5) 12 82
0.1 (0.0-0.2) 1 0.2 (0.1-0.3) 6 70
2.7 (1.8-3.6) 34 5.6 (4.8-6.2) 214 16 HR HPV
0.2 (0.0-0.6) 3 0.9 (0.7-1.2) 35 18
0.2 (0.0-0.4) 2 0.6 (0.4-0.8) 23 31
0.1 (0.0-0.2) 1 0.5 (0.3-0.7) 19 35
0.2 (0.0-0.6) 3 1.2 (0.8-1.5) 45 39
0.1 (0.0-0.2) 1 0.6 (0.4-0.9) 24 45
0.9 (0.4-1.4) 11 1.9 (1.5-2.3) 72 51
0.6 (0.2-1.1) 8 2.2 (1.8-2.7) 86 52
0.4 (0.1-0.7) 4 0.9 (0.6-1.2) 33 56
0.1 (0.0-0.3) 1 0.7 (0.5-1.0) 28 58
0.1 (0.0-0.2) 1 0.5 (0.3-0.8) 21 68
0.2 (0.0-0.6) 3 0.3 (0.1-0.4) 10 59
0.1 (0.0-0.3) 1 0.2 (0.1-0.3) 7 33
14.1 (12.4-15.7) 174 42.1 (40.2-43.9) 1620 Mixed infection*
100.0 1244 100.0 3841 Total